Zobrazeno 1 - 10
of 217
pro vyhledávání: '"Takashi Ura"'
Autor:
Kazunori Honda, Bishal Gyawali, Masashi Ando, Ryosuke Kumanishi, Kyoko Kato, Keiji Sugiyama, Seiichiro Mitani, Toshiki Masuishi, Yukiya Narita, Hideaki Bando, Hiroya Taniguchi, Shigenori Kadowaki, Takashi Ura, Kei Muro
Publikováno v:
Journal of Global Oncology, Vol 5, Pp 1-8 (2019)
PURPOSE: We previously reported on the pilot study assessing the feasibility of using the Japanese translation of the Comprehensive Score for Financial Toxicity (COST) tool to measure financial toxicity (FT) among Japanese patients with cancer. In th
Externí odkaz:
https://doaj.org/article/65301ba3b90c4fffac9baa39cb660bf7
Autor:
Kazunori Honda, Masashi Ando, Keiji Sugiyama, Seiichiro Mitani, Toshiki Masuishi, Yukiya Narita, Hiroya Taniguchi, Shigenori Kadowaki, Takashi Ura, Kei Muro
Publikováno v:
Case Reports in Oncology, Vol 10, Iss 3, Pp 863-870 (2017)
Angiosarcoma of the heart is an uncommon soft tissue sarcoma. A few cases of disseminated intravascular coagulation (DIC) associated with angiosarcoma occurring in various organs, but not the heart, have been reported. Although taxane is commonly use
Externí odkaz:
https://doaj.org/article/e1cbe96da1f64eda8ff8f7dcda81ac12
Autor:
Seiichiro Mitani, Hiroya Taniguchi, Keiji Sugiyama, Toshiki Masuishi, Kazunori Honda, Yukiya Narita, Shigenori Kadowaki, Takashi Ura, Masashi Ando, Masahiro Tajika, Yasushi Yatabe, Kei Muro
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 11 (2019)
Background: BRAF (v-raf murine sarcoma viral oncogene homolog B1) V600E mutant colorectal cancer is associated with short survival. Recently, clinical trials have been conducted to improve outcomes of second or later lines of chemotherapy. However, t
Externí odkaz:
https://doaj.org/article/02a3947da7a14667a2dc215900912389
Autor:
Akihiro Ohba, MD, Ken Kato, MD PhD, Yoshinori Ito, MD, Chikatoshi Katada, MD PhD, Hiromichi Ishiyama, MD PhD, Sachiko Yamamoto, MD, Takashi Ura, MD, Takeshi Kodaira, MD PhD, Shigehiro Kudo, MD, Yoshio Tamaki, MD PhD
Publikováno v:
Advances in Radiation Oncology, Vol 1, Iss 4, Pp 230-236 (2016)
Purpose: The most effective treatments in elderly patients with esophageal cancer remain a subject of debate. This multicenter phase 2 study was designed to evaluate the efficacy and toxicity of chemoradiation therapy (CRT) with docetaxel (DTX) in el
Externí odkaz:
https://doaj.org/article/dcbd30658a474bd6b7a027e7d7a64e4d
Autor:
Kohei Shitara, Tomoya Yokota, Daisuke Takahari, Takashi Shibata, Yozo Sato, Masahiro Tajika, Takashi Ura, Kei Muro
Publikováno v:
Case Reports in Oncology, Vol 3, Iss 2, Pp 282-286 (2010)
Introduction: Cetuximab-based chemotherapy showed a statistically significantly higher response rate compared with chemotherapy such as FOLFOX. Therefore, FOLFOX plus cetuximab is suspected to be the best regimen to alleviate tumor-related symptoms w
Externí odkaz:
https://doaj.org/article/92807a2ba4124df481870d50183df566
Autor:
Takashi Ura, Shuichi Hironaka, Yasuhiro Tsubosa, Junki Mizusawa, Ken Kato, Takahiro Tsushima, Kunihiro Fushiki, Keisho Chin, Akihisa Tomori, Tatsuya Okuno, Hisayuki Matsushita, Takashi Kojima, Yuichiro Doki, Hitoshi Kusaba, Kazumasa Fujitani, Shiko Seki, Yuko Kitagawa
Publikováno v:
Esophagus. 20:272-280
We herein investigated the association between early tumor shrinkage (ETS) and depth of response (DpR) and clinical outcomes in patients with metastatic esophageal cancer treated with 2-weekly docetaxel combined with cisplatin plus fluorouracil (bDCF
Autor:
Hiroya, Takeuchi, Yoshinori, Ito, Ryunosuke, Machida, Ken, Kato, Masakatsu, Onozawa, Keiko, Minashi, Tomonori, Yano, Kenichi, Nakamura, Takahiro, Tsushima, Hiroki, Hara, Tatsuya, Okuno, Shuichi, Hironaka, Isao, Nozaki, Takashi, Ura, Keisho, Chin, Takashi, Kojima, Shiko, Seki, Katsuyuki, Sakanaka, Haruhiko, Fukuda, Yuko, Kitagawa
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 114:454-462
Definitive chemoradiotherapy (CRT) is the standard treatment for patients with locally advanced esophageal cancer (EC) who refuse surgery as the initial therapy. However, poor survival, a high incidence of late toxicities, and severe complications af
Autor:
Tomohiro Kondo, Masashi Kanai, Junichi Matsubara, Daisuke Yamaguchi, Takashi Ura, Tadayuki Kou, Toshinao Itani, Motoo Nomura, Taro Funakoshi, Akira Yokoyama, Keitaro Doi, Masashi Tamaoki, Michio Yoshimura, Norimitsu Uza, Takahiro Yamada, Toshihiko Masui, Sachiko Minamiguchi, Shigemi Matsumoto, Hideki Ishikawa, Manabu Muto
Publikováno v:
Medical Oncology. 40
Autor:
Keitaro Matsuo, Hideo Tanaka, Yasushi Yatabe, Kazuo Tajima, Miki Watanabe, Takakazu Kawase, Satoyo Hosono, Hidemi Ito, Takashi Ura, Takashi Shibata, Daisuke Takahari, Tomoya Yokota, Hiroki Kawai, Masahiro Tajika, Akira Sawaki, Seiji Ito, Kei Muro, Kohei Shitara
Background: A relationship between dietary folate intake and efficacy of fluorouracil (FU) is supported by preclinical data. Furthermore, there are several reports that evaluated genetic polymorphisms of MTHFR (methylenetetrahydrofolate reductase) or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::186094323fec93d5bf7949bf61caf3a3
https://doi.org/10.1158/1055-9965.c.6515139
https://doi.org/10.1158/1055-9965.c.6515139
Autor:
Keitaro Matsuo, Hideo Tanaka, Yasushi Yatabe, Kazuo Tajima, Miki Watanabe, Takakazu Kawase, Satoyo Hosono, Hidemi Ito, Takashi Ura, Takashi Shibata, Daisuke Takahari, Tomoya Yokota, Hiroki Kawai, Masahiro Tajika, Akira Sawaki, Seiji Ito, Kei Muro, Kohei Shitara
Supplementary Tables 1-3 from Folate Intake along with Genetic Polymorphisms in Methylenetetrahydrofolate Reductase and Thymidylate Synthase in Patients with Advanced Gastric Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3040f610d58ec527dd967ea5a0977d2e
https://doi.org/10.1158/1055-9965.22435875
https://doi.org/10.1158/1055-9965.22435875